Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms

Area of Science:

• Biochemistry
• Genetics
• Metabolic Disease Research

Background:

• Ectopic fat deposition impairs organ function, contributing to metabolic disorders such as diabetes, heart disease, and hypertension.
• Current therapeutics (e.g., thiazolidinediones, metformin, statins) mitigate metabolic disease by limiting inappropriate fat storage.
• Genomic and lipidomic advancements enhance understanding of fat metabolism's role in disease pathogenesis.

Purpose of the Study:

• To review pharmacological and genetic strategies targeting enzymes that control lipid deposition.
• To elucidate the molecular mechanisms linking fatty acids to metabolic disease through enzyme manipulation.

Main Methods:

• Review of studies employing pharmacological interventions.
• Analysis of genetic strategies to alter enzyme expression or activity related to lipid metabolism.
• Integration of findings from genomics and lipidomics.

Main Results:

• Identification of key enzymes regulating lipid deposition and their role in metabolic dysfunction.
• Demonstration that manipulating these enzymes can impact cellular fat accumulation.
• Insights into the molecular pathways affected by altered lipid metabolism.

Conclusions:

• Targeting enzymes involved in lipid metabolism offers a promising therapeutic avenue for metabolic diseases.
• Understanding the molecular mechanisms of fatty acid lipotoxicity is crucial for developing effective treatments.
• Pharmacological and genetic manipulation of lipid-regulating enzymes provides valuable insights into disease pathology.